
Shandong
688136.SSShandong Kexing Bioproducts Co,.Ltd Price (688136.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
198,219,089
(0.2424)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
Shandong Kexing Bioproducts Co,.LtdCurrency: CNY
YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
615.84M
+0% |
890.61M
+45% |
1.19B
+34% |
1.22B
+2% |
1.29B
+5% |
1.32B
+2% |
1.26B
-4% |
||||||||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 129.12M | 168.24M | 219.95M | 244.27M | 264.62M | 324.16M | 370.31M | ||||||||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
486.72M
+0% |
722.37M
+48% |
970.81M
+34% |
976.02M
+1% |
1.02B
+5% |
991.71M
-3% |
888.72M
-10% |
||||||||||||
Gross Profit Ratio | (0.79%) | (0.81%) | (0.82%) | (0.80%) | (0.79%) | (0.75%) | (0.71%) | ||||||||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 32.35M | 42.68M | 46.17M | 60.11M | 122.95M | 193.30M | 344.80M | ||||||||||||
General and Administrative | 9.35M | 54.08M | 22.72M | 20.05M | 29.90M | 28.44M | 7.69M | ||||||||||||
Selling, General & Admin... | 337.01M | 522.16M | 669.94M | 675.59M | 785.50M | 856.17M | 627.66M | ||||||||||||
Selling & Marketing Exp... | 327.65M | 468.08M | 647.22M | 655.54M | 755.60M | 827.73M | 619.96M | ||||||||||||
Depreciation and Amortiz... | 8.20M | 9.39M | 12.89M | 33.69M | 56.63M | 81.01M | 88.26M | ||||||||||||
Other Expenses | -14,697,519.11 | -1,687.61 | 44.81M | 56.54M | 66.35M | 62.05M | 175.06M | ||||||||||||
Total Operating Expenses | 386.18M | 580.34M | 760.92M | 792.24M | 974.80M | 1.11B | 1.15B | ||||||||||||
Cost and Exponses | 515.30M | 748.58M | 980.87M | 1.04B | 1.24B | 1.44B | 1.52B | ||||||||||||
Operating Income | |||||||||||||||||||
Operating Income |
89.32M
+0% |
121.27M
+36% |
188.98M
+56% |
159.85M
-15% |
55.57M
-65% |
-119,805,590.44
-316% |
-254,201,900.00
+112% |
||||||||||||
Operating Income Ratio | (0.15%) | (0.14%) | (0.16%) | (0.13%) | (0.04%) | (-0.09%) | (-0.20%) | ||||||||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 260.85k | 221.09k | 345.96k | 937.64k | 9.06M | 7.31M | 6.64M | ||||||||||||
Interest Expenses | 6.69M | 11.16M | 6.67M | 10.33M | 8.03M | 26.31M | 41.12M | ||||||||||||
Total Other Income/Exp... | -24,105,037.00 | -1,688.00 | -11,890,397.00 | -19,402,043.00 | 40.06M | -19,258,714.56 | -5,868,067.00 | ||||||||||||
EBITDA | |||||||||||||||||||
EBITDA | 89.66M | 143.82M | 213.90M | 209.75M | 164.81M | -28,868,146.00 | -132,676,252.93 | ||||||||||||
EBITDA ratio | (0.16%) | (0.18%) | (0.19%) | (0.17%) | (0.08%) | (-0.03%) | (-0.11%) | ||||||||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 74.62M | 121.27M | 187.78M | 159.16M | 95.63M | -139,064,305.67 | -260,069,967.00 | ||||||||||||
Income Before Tax Ratio | (0.12%) | (0.14%) | (0.16%) | (0.13%) | (0.07%) | (-0.11%) | (-0.21%) | ||||||||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 15.23M | 27.10M | 27.97M | 20.02M | -836,849.70 | -46,240,444.47 | -64,583,444.00 | ||||||||||||
Net Income | |||||||||||||||||||
Net Income | 59.39M
+0% |
94.16M
+59% |
159.81M
+70% |
139.14M
-13% |
96.46M
-31% |
-92,823,861.20
-196% |
-190,290,325.00
+105% |
||||||||||||
Net Income Ratio | (0.10%) | (0.11%) | (0.13%) | (0.11%) | (0.08%) | (-0.07%) | (-0.15%) | ||||||||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | 0.97 | 1.54 | 0.80 | 0.70 | 0.49 | -0.47 | -0.96 | ||||||||||||
Diluted EPS | 0.97 | 1.54 | 0.80 | 0.70 | 0.49 | -0.47 | -0.96 | ||||||||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 61.23M | 61.15M | 198.70M | 198.70M | 198.70M | 198.70M | 198.22M | ||||||||||||
Diluted Share Outstanding | 61.23M | 61.15M | 198.70M | 198.70M | 198.70M | 198.70M | 198.22M |